Crohn's Disease Clinical Trials in Philadelphia

Showing 21-40 of 130 trials

Exploring Multiple Self-Help Interventions to Promote Self-Efficacy and Overcome Disability

NCT06646757

EMPOWER-IBD aims to identify behavioral interventions to strengthen patients' self-efficacy for self-management as a mechanism to reduce IBD-related disability. This multisite, randomized controlled trial with 16 arms will randomize adults with moderate-to-severe IBD-related disability to a combination of four multimodal behavioral interventions to test their clinical effectiveness in reducing IBD-related disability and improving self-efficacy. The interventions are four existing, publicly available disease-specific self-help resources offered at no cost to the participants: a book, smart app, help center, and peer mentor. Participants will complete online surveys and may engage in virtual focus groups. Participants may receive an honorarium (e-gift card) and/or be entered into a lottery for a giftcards post-survey completion and focus group participation.

Ulcerative Colitis (UC)Crohn Disease (CD)

University of Pennsylvania803 participantsStarted Aug 2024

Philadelphia, Pennsylvania, United States

TERMINATEDPhase 3< 1 mile

A Placebo-Controlled Study of Oral Ozanimod as Maintenance Therapy for Moderately to Severely Active Crohn's Disease

NCT03464097

This is a study to demonstrate the effect of oral ozanimod as maintenance therapy in participants with moderately to severely active Crohn's Disease.

Crohn Disease

Celgene550 participantsStarted Jun 2018

Peoria, Arizona, United States • Scottsdale, Arizona, United States • North Little Rock, Arkansas, United States +762 more locations

Exploring Multiple Self-Help Interventions to Promote Self-Efficacy and Overcome Disability

A Placebo-Controlled Study of Oral Ozanimod as Maintenance Therapy for Moderately to Severely Active Crohn's Disease

Crohn's Disease Trials in Other Cities

An Extension Study of Oral Ozanimod for Moderately to Severely Active Crohn's Disease

A Maintenance and Long-Term Extension Study of the Efficacy and Safety of Upadacitinib (ABT-494) in Participants With Crohn's Disease Who Completed the Studies M14-431 or M14-433

A Study to Evaluate the Safety and Efficacy of Ustekinumab Induction and Maintenance Therapy in Participants With Moderately to Severely Active Ulcerative Colitis

A Study of Ustekinumab in Pediatric Participants With Moderately to Severely Active Crohn's Disease

A Study Evaluating the Efficacy and Safety of Oral Etrasimod in the Treatment of Adult Participants With Moderately to Severely Active Crohn's Disease

A Study to Evaluate MORF-057 in Adults With Moderately to Severely Active UC

Treatment of Moderate to Severe Refractory Crohn's Disease

A Study of CDPATH™ to Help Manage and Treat Crohn's Disease

Moving Beyond Inflammation as a Therapeutic Target for Crohn's Disease

Study of Efficacy and Adherence to Subcutaneous vs. Intravenous Vedolizumab in Patients With Inflammatory Bowel Disease Using a Novel Remote MONITORing Intervention

Efficacy and Safety of Obefazimod in Subjects With Moderately to Severely Active Crohn's Disease

Afimkibart (RO7790121) for the Treatment of Moderate to Severe Active Crohn's Disease

STENOVA - A Study to Evaluate Safety, Tolerability, PK and PD of AGMB-129 in Patients With Fibrostenotic Crohn's Disease

Pilot and Feasibility Study of 2'-FL as a Dietary Supplement in IBD Patients Receiving Stable Maintenance Anti-TNF Therapy

Personalized AZithromycin/metronidAZole Therapy in Pediatric Crohn's Disease (CD)

A Study to Test Whether BI 706321 Combined With Ustekinumab Helps People With Crohn's Disease

Stopping Aminosalicylate Therapy in Inactive Crohn's Disease

A Study to Evaluate the Effect of Ustekinumab on Cytochrome P450 Enzyme Activities Following Induction and Maintenance Dosing in Participants With Active Crohn's Disease or Ulcerative Colitis

Other Conditions in Philadelphia